Controversy in Cancer Screening: Lung Cancer

Extensive debate exists over lung cancer screening. The increasing incidence of lung cancer and the poor survival rate for advanced disease, despite the advances in drug therapy, have increased the interest in implementing extensive lung cancer screening.

Some studies, such as The National Lung Screening Trial, the International Early Lung Cancer Program, and other major screening studies, favor screening with low-dose CT scans and have shown a reduction in lung cancer-specific mortality.

On the other hand, concerns over imaging workflow, radiation dose, management of small nodules with potential overdiagnosis bias, lead-time and length-time bias, and cost-effectiveness continue to be debated.

This hot topic will be addressed in our webinar by two Key Opinion Leaders.

Access

Public

Year

2023